nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitric Oxide—CYP2B6—Thiotepa—urinary bladder cancer	0.301	0.443	CbGbCtD
Nitric Oxide—CYP3A4—Thiotepa—urinary bladder cancer	0.0925	0.136	CbGbCtD
Nitric Oxide—CYP2B6—Cisplatin—urinary bladder cancer	0.0831	0.122	CbGbCtD
Nitric Oxide—CYP1A2—Fluorouracil—urinary bladder cancer	0.0573	0.0844	CbGbCtD
Nitric Oxide—CYP2B6—Doxorubicin—urinary bladder cancer	0.0557	0.0819	CbGbCtD
Nitric Oxide—CYP1A2—Etoposide—urinary bladder cancer	0.0479	0.0704	CbGbCtD
Nitric Oxide—CYP3A4—Etoposide—urinary bladder cancer	0.0251	0.0369	CbGbCtD
Nitric Oxide—CYP3A4—Doxorubicin—urinary bladder cancer	0.0171	0.0252	CbGbCtD
Nitric Oxide—GUCY1A2—prostate gland—urinary bladder cancer	0.014	0.0808	CbGeAlD
Nitric Oxide—CYP1A2—urine—urinary bladder cancer	0.00966	0.056	CbGeAlD
Nitric Oxide—GUCY1A3—prostate gland—urinary bladder cancer	0.00879	0.0509	CbGeAlD
Nitric Oxide—GUCY1B3—prostate gland—urinary bladder cancer	0.00873	0.0505	CbGeAlD
Nitric Oxide—GUCY1A2—female reproductive system—urinary bladder cancer	0.00762	0.0441	CbGeAlD
Nitric Oxide—GUCY1A3—seminal vesicle—urinary bladder cancer	0.00744	0.0431	CbGeAlD
Nitric Oxide—ALDH2—prostate gland—urinary bladder cancer	0.00741	0.0429	CbGeAlD
Nitric Oxide—GUCY1B3—seminal vesicle—urinary bladder cancer	0.00738	0.0427	CbGeAlD
Nitric Oxide—CYP3A4—urine—urinary bladder cancer	0.007	0.0405	CbGeAlD
Nitric Oxide—ALDH2—seminal vesicle—urinary bladder cancer	0.00627	0.0363	CbGeAlD
Nitric Oxide—GUCY1A3—renal system—urinary bladder cancer	0.00599	0.0347	CbGeAlD
Nitric Oxide—GUCY1B3—renal system—urinary bladder cancer	0.00595	0.0344	CbGeAlD
Nitric Oxide—GUCY1A3—urethra—urinary bladder cancer	0.00589	0.0341	CbGeAlD
Nitric Oxide—GUCY1B3—urethra—urinary bladder cancer	0.00584	0.0338	CbGeAlD
Nitric Oxide—ALDH2—smooth muscle tissue—urinary bladder cancer	0.00525	0.0304	CbGeAlD
Nitric Oxide—ALDH2—renal system—urinary bladder cancer	0.00505	0.0292	CbGeAlD
Nitric Oxide—ALDH2—urethra—urinary bladder cancer	0.00496	0.0287	CbGeAlD
Nitric Oxide—GUCY1A3—female reproductive system—urinary bladder cancer	0.0048	0.0278	CbGeAlD
Nitric Oxide—GUCY1B3—female reproductive system—urinary bladder cancer	0.00476	0.0276	CbGeAlD
Nitric Oxide—GUCY1A2—lymph node—urinary bladder cancer	0.00446	0.0258	CbGeAlD
Nitric Oxide—GUCY1A3—vagina—urinary bladder cancer	0.00434	0.0251	CbGeAlD
Nitric Oxide—GUCY1B3—vagina—urinary bladder cancer	0.00431	0.025	CbGeAlD
Nitric Oxide—ALDH2—female reproductive system—urinary bladder cancer	0.00404	0.0234	CbGeAlD
Nitric Oxide—ALDH2—vagina—urinary bladder cancer	0.00366	0.0212	CbGeAlD
Nitric Oxide—GUCY1A3—lymph node—urinary bladder cancer	0.00281	0.0163	CbGeAlD
Nitric Oxide—GUCY1B3—lymph node—urinary bladder cancer	0.00279	0.0161	CbGeAlD
Nitric Oxide—ALDH2—lymph node—urinary bladder cancer	0.00237	0.0137	CbGeAlD
Nitric Oxide—CYP1A2—renal system—urinary bladder cancer	0.00236	0.0137	CbGeAlD
Nitric Oxide—CYP2B6—renal system—urinary bladder cancer	0.00227	0.0131	CbGeAlD
Nitric Oxide—Chest pain—Valrubicin—urinary bladder cancer	0.00182	0.034	CcSEcCtD
Nitric Oxide—CYP2B6—female reproductive system—urinary bladder cancer	0.00182	0.0105	CbGeAlD
Nitric Oxide—CYP3A4—renal system—urinary bladder cancer	0.00171	0.00991	CbGeAlD
Nitric Oxide—CYP2B6—vagina—urinary bladder cancer	0.00164	0.00951	CbGeAlD
Nitric Oxide—Chest discomfort—Etoposide—urinary bladder cancer	0.00137	0.0257	CcSEcCtD
Nitric Oxide—CYP3A4—female reproductive system—urinary bladder cancer	0.00137	0.00794	CbGeAlD
Nitric Oxide—Pneumothorax—Epirubicin—urinary bladder cancer	0.00137	0.0256	CcSEcCtD
Nitric Oxide—Pneumothorax—Doxorubicin—urinary bladder cancer	0.00127	0.0237	CcSEcCtD
Nitric Oxide—Shock—Mitomycin—urinary bladder cancer	0.00118	0.0221	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.00117	0.022	CcSEcCtD
Nitric Oxide—Dizziness—Valrubicin—urinary bladder cancer	0.00115	0.0215	CcSEcCtD
Nitric Oxide—Headache—Valrubicin—urinary bladder cancer	0.00109	0.0204	CcSEcCtD
Nitric Oxide—Dyspnoea—Mitomycin—urinary bladder cancer	0.00107	0.02	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Fluorouracil—urinary bladder cancer	0.00102	0.019	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Cisplatin—urinary bladder cancer	0.000963	0.018	CcSEcCtD
Nitric Oxide—CYP2B6—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000892	0.00947	CbGpPWpGaD
Nitric Oxide—Haemoglobin—Thiotepa—urinary bladder cancer	0.000854	0.016	CcSEcCtD
Nitric Oxide—Haemorrhage—Thiotepa—urinary bladder cancer	0.000849	0.0159	CcSEcCtD
Nitric Oxide—Dizziness—Mitomycin—urinary bladder cancer	0.000794	0.0148	CcSEcCtD
Nitric Oxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000791	0.0084	CbGpPWpGaD
Nitric Oxide—Cardiac disorder—Thiotepa—urinary bladder cancer	0.000788	0.0147	CcSEcCtD
Nitric Oxide—Angiopathy—Thiotepa—urinary bladder cancer	0.000771	0.0144	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Thiotepa—urinary bladder cancer	0.000766	0.0143	CcSEcCtD
Nitric Oxide—CYP1A2—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.000752	0.00799	CbGpPWpGaD
Nitric Oxide—Headache—Mitomycin—urinary bladder cancer	0.000752	0.0141	CcSEcCtD
Nitric Oxide—CYP1A2—Estrogen metabolism—NQO1—urinary bladder cancer	0.000731	0.00776	CbGpPWpGaD
Nitric Oxide—Haemoglobin—Gemcitabine—urinary bladder cancer	0.000718	0.0134	CcSEcCtD
Nitric Oxide—Haemorrhage—Gemcitabine—urinary bladder cancer	0.000715	0.0134	CcSEcCtD
Nitric Oxide—Haemoglobin—Fluorouracil—urinary bladder cancer	0.000706	0.0132	CcSEcCtD
Nitric Oxide—Haemorrhage—Fluorouracil—urinary bladder cancer	0.000703	0.0131	CcSEcCtD
Nitric Oxide—Bradycardia—Cisplatin—urinary bladder cancer	0.000678	0.0127	CcSEcCtD
Nitric Oxide—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.000663	0.0124	CcSEcCtD
Nitric Oxide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00065	0.00691	CbGpPWpGaD
Nitric Oxide—Angiopathy—Gemcitabine—urinary bladder cancer	0.000648	0.0121	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.000644	0.012	CcSEcCtD
Nitric Oxide—CYP1A2—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000642	0.00682	CbGpPWpGaD
Nitric Oxide—Convulsion—Thiotepa—urinary bladder cancer	0.000641	0.012	CcSEcCtD
Nitric Oxide—ALDH2—Biological oxidations—GSTP1—urinary bladder cancer	0.000641	0.00681	CbGpPWpGaD
Nitric Oxide—Cardiac disorder—Cisplatin—urinary bladder cancer	0.000618	0.0116	CcSEcCtD
Nitric Oxide—CYP1A2—Phase II conjugation—GSTZ1—urinary bladder cancer	0.000613	0.00651	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GSTZ1—urinary bladder cancer	0.000609	0.00647	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000601	0.00638	CbGpPWpGaD
Nitric Oxide—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.0006	0.0112	CcSEcCtD
Nitric Oxide—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000592	0.0111	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000591	0.011	CcSEcCtD
Nitric Oxide—ALDH2—Biological oxidations—GSTM1—urinary bladder cancer	0.000589	0.00625	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—GSTO2—urinary bladder cancer	0.000581	0.00618	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—NAT1—urinary bladder cancer	0.000581	0.00618	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GSTO2—urinary bladder cancer	0.000578	0.00614	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—NAT1—urinary bladder cancer	0.000578	0.00614	CbGpPWpGaD
Nitric Oxide—CYP1A2—Estrogen Receptor Pathway—ESR1—urinary bladder cancer	0.000571	0.00606	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00057	0.00605	CbGpPWpGaD
Nitric Oxide—Cardiac disorder—Etoposide—urinary bladder cancer	0.000566	0.0106	CcSEcCtD
Nitric Oxide—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.000564	0.00599	CbGpPWpGaD
Nitric Oxide—CYP1A2—Estrogen metabolism—GSTM1—urinary bladder cancer	0.00056	0.00595	CbGpPWpGaD
Nitric Oxide—Angiopathy—Etoposide—urinary bladder cancer	0.000554	0.0103	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Etoposide—urinary bladder cancer	0.00055	0.0103	CcSEcCtD
Nitric Oxide—CYP1A2—Phase II conjugation—UGT2B7—urinary bladder cancer	0.000532	0.00565	CbGpPWpGaD
Nitric Oxide—Convulsion—Fluorouracil—urinary bladder cancer	0.00053	0.00991	CcSEcCtD
Nitric Oxide—Chest pain—Gemcitabine—urinary bladder cancer	0.00053	0.0099	CcSEcCtD
Nitric Oxide—CYP2B6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000528	0.00561	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000527	0.0056	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000521	0.00553	CbGpPWpGaD
Nitric Oxide—Chest pain—Fluorouracil—urinary bladder cancer	0.000521	0.00973	CcSEcCtD
Nitric Oxide—GUCY1B3—Hemostasis—IFNA2—urinary bladder cancer	0.000508	0.0054	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—IFNA2—urinary bladder cancer	0.000508	0.0054	CbGpPWpGaD
Nitric Oxide—Convulsion—Cisplatin—urinary bladder cancer	0.000502	0.00939	CcSEcCtD
Nitric Oxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000502	0.00533	CbGpPWpGaD
Nitric Oxide—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000498	0.00931	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000497	0.00929	CcSEcCtD
Nitric Oxide—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000495	0.00526	CbGpPWpGaD
Nitric Oxide—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.000494	0.00924	CcSEcCtD
Nitric Oxide—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000489	0.00915	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000489	0.00914	CcSEcCtD
Nitric Oxide—CYP2B6—Biological oxidations—CYP4B1—urinary bladder cancer	0.000476	0.00505	CbGpPWpGaD
Nitric Oxide—Hypotension—Gemcitabine—urinary bladder cancer	0.000474	0.00887	CcSEcCtD
Nitric Oxide—CYP2B6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000469	0.00498	CbGpPWpGaD
Nitric Oxide—Hypotension—Fluorouracil—urinary bladder cancer	0.000466	0.00872	CcSEcCtD
Nitric Oxide—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000464	0.00867	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000463	0.00866	CcSEcCtD
Nitric Oxide—Convulsion—Etoposide—urinary bladder cancer	0.00046	0.0086	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.000457	0.00855	CcSEcCtD
Nitric Oxide—GUCY1A3—Hemostasis—IFNA2—urinary bladder cancer	0.000453	0.00481	CbGpPWpGaD
Nitric Oxide—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000453	0.00846	CcSEcCtD
Nitric Oxide—Chest pain—Etoposide—urinary bladder cancer	0.000452	0.00845	CcSEcCtD
Nitric Oxide—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000445	0.00832	CcSEcCtD
Nitric Oxide—Hypotension—Cisplatin—urinary bladder cancer	0.000442	0.00826	CcSEcCtD
Nitric Oxide—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000432	0.00459	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.000428	0.00455	CbGpPWpGaD
Nitric Oxide—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000424	0.00793	CcSEcCtD
Nitric Oxide—Dyspnoea—Cisplatin—urinary bladder cancer	0.000422	0.00789	CcSEcCtD
Nitric Oxide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.00041	0.00435	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000407	0.00432	CbGpPWpGaD
Nitric Oxide—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000405	0.00431	CbGpPWpGaD
Nitric Oxide—Hypotension—Etoposide—urinary bladder cancer	0.000405	0.00757	CcSEcCtD
Nitric Oxide—CYP1A2—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.0004	0.00425	CbGpPWpGaD
Nitric Oxide—Dizziness—Thiotepa—urinary bladder cancer	0.000399	0.00746	CcSEcCtD
Nitric Oxide—ALDH2—Metabolism—GSTZ1—urinary bladder cancer	0.000392	0.00417	CbGpPWpGaD
Nitric Oxide—Dyspnoea—Etoposide—urinary bladder cancer	0.000386	0.00722	CcSEcCtD
Nitric Oxide—Headache—Thiotepa—urinary bladder cancer	0.000378	0.00707	CcSEcCtD
Nitric Oxide—ALDH2—Metabolism—GSTO2—urinary bladder cancer	0.000372	0.00395	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—NAT1—urinary bladder cancer	0.000372	0.00395	CbGpPWpGaD
Nitric Oxide—Haemoglobin—Methotrexate—urinary bladder cancer	0.000367	0.00687	CcSEcCtD
Nitric Oxide—Haemorrhage—Methotrexate—urinary bladder cancer	0.000365	0.00683	CcSEcCtD
Nitric Oxide—GUCY1A2—Hemostasis—PLAU—urinary bladder cancer	0.000361	0.00383	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PLAU—urinary bladder cancer	0.000361	0.00383	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GSTZ1—urinary bladder cancer	0.000359	0.00381	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000354	0.00376	CbGpPWpGaD
Nitric Oxide—Bradycardia—Epirubicin—urinary bladder cancer	0.000348	0.00651	CcSEcCtD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.000345	0.00366	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000345	0.00366	CbGpPWpGaD
Nitric Oxide—Haemoglobin—Epirubicin—urinary bladder cancer	0.000344	0.00643	CcSEcCtD
Nitric Oxide—Haemorrhage—Epirubicin—urinary bladder cancer	0.000342	0.00639	CcSEcCtD
Nitric Oxide—ALDH2—Metabolism—UGT2B7—urinary bladder cancer	0.00034	0.00361	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GSTO2—urinary bladder cancer	0.00034	0.00361	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—NAT1—urinary bladder cancer	0.00034	0.00361	CbGpPWpGaD
Nitric Oxide—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000339	0.00634	CcSEcCtD
Nitric Oxide—CYP1A2—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000335	0.00356	CbGpPWpGaD
Nitric Oxide—Angiopathy—Methotrexate—urinary bladder cancer	0.000332	0.0062	CcSEcCtD
Nitric Oxide—Dizziness—Fluorouracil—urinary bladder cancer	0.00033	0.00617	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000329	0.00616	CcSEcCtD
Nitric Oxide—Bradycardia—Doxorubicin—urinary bladder cancer	0.000322	0.00602	CcSEcCtD
Nitric Oxide—GUCY1A3—Hemostasis—PLAU—urinary bladder cancer	0.000322	0.00342	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—NAT2—urinary bladder cancer	0.000319	0.00338	CbGpPWpGaD
Nitric Oxide—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000318	0.00595	CcSEcCtD
Nitric Oxide—Headache—Gemcitabine—urinary bladder cancer	0.000318	0.00594	CcSEcCtD
Nitric Oxide—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000317	0.00593	CcSEcCtD
Nitric Oxide—CYP2B6—Biological oxidations—NAT2—urinary bladder cancer	0.000316	0.00336	CbGpPWpGaD
Nitric Oxide—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000316	0.00592	CcSEcCtD
Nitric Oxide—Headache—Fluorouracil—urinary bladder cancer	0.000313	0.00585	CcSEcCtD
Nitric Oxide—CYP2B6—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000312	0.00332	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—UGT2B7—urinary bladder cancer	0.000311	0.0033	CbGpPWpGaD
Nitric Oxide—Angiopathy—Epirubicin—urinary bladder cancer	0.00031	0.0058	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000308	0.00576	CcSEcCtD
Nitric Oxide—CYP1A2—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000307	0.00326	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CYP4B1—urinary bladder cancer	0.000306	0.00325	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—CREBBP—urinary bladder cancer	0.000298	0.00316	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—CREBBP—urinary bladder cancer	0.000298	0.00316	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—IGF1—urinary bladder cancer	0.000294	0.00312	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—IGF1—urinary bladder cancer	0.000294	0.00312	CbGpPWpGaD
Nitric Oxide—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000294	0.00549	CcSEcCtD
Nitric Oxide—ALDH2—Metabolism—SLC19A1—urinary bladder cancer	0.000289	0.00307	CbGpPWpGaD
Nitric Oxide—Angiopathy—Doxorubicin—urinary bladder cancer	0.000287	0.00537	CcSEcCtD
Nitric Oxide—Dizziness—Etoposide—urinary bladder cancer	0.000287	0.00536	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000285	0.00533	CcSEcCtD
Nitric Oxide—ALDH2—Metabolism—PRSS3—urinary bladder cancer	0.000282	0.003	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—CYP4B1—urinary bladder cancer	0.00028	0.00298	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000277	0.00294	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000276	0.00293	CbGpPWpGaD
Nitric Oxide—Convulsion—Methotrexate—urinary bladder cancer	0.000276	0.00515	CcSEcCtD
Nitric Oxide—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000273	0.0029	CbGpPWpGaD
Nitric Oxide—Headache—Etoposide—urinary bladder cancer	0.000272	0.00508	CcSEcCtD
Nitric Oxide—Chest pain—Methotrexate—urinary bladder cancer	0.000271	0.00506	CcSEcCtD
Nitric Oxide—GUCY1B3—Hemostasis—RHOA—urinary bladder cancer	0.000269	0.00286	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—RHOA—urinary bladder cancer	0.000269	0.00286	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—CREBBP—urinary bladder cancer	0.000265	0.00282	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000262	0.00279	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000262	0.00279	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—IGF1—urinary bladder cancer	0.000262	0.00278	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000259	0.00275	CbGpPWpGaD
Nitric Oxide—Convulsion—Epirubicin—urinary bladder cancer	0.000258	0.00482	CcSEcCtD
Nitric Oxide—CYP1A2—Phase II conjugation—HPGDS—urinary bladder cancer	0.000255	0.00271	CbGpPWpGaD
Nitric Oxide—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000255	0.00476	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000254	0.00475	CcSEcCtD
Nitric Oxide—Chest pain—Epirubicin—urinary bladder cancer	0.000253	0.00474	CcSEcCtD
Nitric Oxide—CYP2B6—Biological oxidations—HPGDS—urinary bladder cancer	0.000253	0.00269	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—GSTT1—urinary bladder cancer	0.000247	0.00262	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GSTT1—urinary bladder cancer	0.000245	0.00261	CbGpPWpGaD
Nitric Oxide—Hypotension—Methotrexate—urinary bladder cancer	0.000243	0.00454	CcSEcCtD
Nitric Oxide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000241	0.00256	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.00024	0.00255	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—RHOA—urinary bladder cancer	0.00024	0.00255	CbGpPWpGaD
Nitric Oxide—Shock—Epirubicin—urinary bladder cancer	0.000239	0.00447	CcSEcCtD
Nitric Oxide—Convulsion—Doxorubicin—urinary bladder cancer	0.000239	0.00446	CcSEcCtD
Nitric Oxide—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000238	0.00445	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000238	0.00445	CcSEcCtD
Nitric Oxide—CYP1A2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000237	0.00252	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000237	0.00252	CbGpPWpGaD
Nitric Oxide—Chest pain—Doxorubicin—urinary bladder cancer	0.000235	0.00438	CcSEcCtD
Nitric Oxide—Dyspnoea—Methotrexate—urinary bladder cancer	0.000231	0.00433	CcSEcCtD
Nitric Oxide—Hypotension—Epirubicin—urinary bladder cancer	0.000227	0.00424	CcSEcCtD
Nitric Oxide—GUCY1A2—Hemostasis—IL2—urinary bladder cancer	0.000226	0.0024	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—IL2—urinary bladder cancer	0.000226	0.0024	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—TYMP—urinary bladder cancer	0.000225	0.00239	CbGpPWpGaD
Nitric Oxide—Shock—Doxorubicin—urinary bladder cancer	0.000221	0.00413	CcSEcCtD
Nitric Oxide—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00022	0.00412	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00022	0.00411	CcSEcCtD
Nitric Oxide—Dyspnoea—Epirubicin—urinary bladder cancer	0.000217	0.00405	CcSEcCtD
Nitric Oxide—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000216	0.0023	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000213	0.00226	CbGpPWpGaD
Nitric Oxide—Hypotension—Doxorubicin—urinary bladder cancer	0.00021	0.00393	CcSEcCtD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000208	0.00221	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—NAT2—urinary bladder cancer	0.000204	0.00217	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—EP300—urinary bladder cancer	0.000203	0.00215	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—EP300—urinary bladder cancer	0.000203	0.00215	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—IL2—urinary bladder cancer	0.000201	0.00214	CbGpPWpGaD
Nitric Oxide—Dyspnoea—Doxorubicin—urinary bladder cancer	0.0002	0.00375	CcSEcCtD
Nitric Oxide—GUCY1A2—Hemostasis—SRC—urinary bladder cancer	0.000197	0.00209	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—SRC—urinary bladder cancer	0.000197	0.00209	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	0.000186	0.00198	CbGpPWpGaD
Nitric Oxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000186	0.00198	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000184	0.00195	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000181	0.00193	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—EP300—urinary bladder cancer	0.000181	0.00192	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—RRM2—urinary bladder cancer	0.000176	0.00187	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—SRC—urinary bladder cancer	0.000176	0.00187	CbGpPWpGaD
Nitric Oxide—Dizziness—Methotrexate—urinary bladder cancer	0.000172	0.00321	CcSEcCtD
Nitric Oxide—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.000171	0.00182	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GSTP1—urinary bladder cancer	0.00017	0.00181	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000168	0.00178	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000167	0.00178	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—KRAS—urinary bladder cancer	0.000163	0.00173	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—KRAS—urinary bladder cancer	0.000163	0.00173	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—ENO2—urinary bladder cancer	0.000163	0.00173	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—HPGDS—urinary bladder cancer	0.000163	0.00173	CbGpPWpGaD
Nitric Oxide—Headache—Methotrexate—urinary bladder cancer	0.000163	0.00304	CcSEcCtD
Nitric Oxide—Dizziness—Epirubicin—urinary bladder cancer	0.000161	0.003	CcSEcCtD
Nitric Oxide—ALDH2—Metabolism—GSTT1—urinary bladder cancer	0.000158	0.00168	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000157	0.00167	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GSTM1—urinary bladder cancer	0.000156	0.00166	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000154	0.00164	CbGpPWpGaD
Nitric Oxide—Headache—Epirubicin—urinary bladder cancer	0.000152	0.00285	CcSEcCtD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000149	0.00158	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.000149	0.00158	CbGpPWpGaD
Nitric Oxide—Dizziness—Doxorubicin—urinary bladder cancer	0.000149	0.00278	CcSEcCtD
Nitric Oxide—GUCY1A3—Hemostasis—KRAS—urinary bladder cancer	0.000145	0.00155	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—TP53—urinary bladder cancer	0.000145	0.00154	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—TP53—urinary bladder cancer	0.000145	0.00154	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000144	0.00153	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000144	0.00153	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000142	0.00151	CbGpPWpGaD
Nitric Oxide—Headache—Doxorubicin—urinary bladder cancer	0.000141	0.00263	CcSEcCtD
Nitric Oxide—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000139	0.00148	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—HRAS—urinary bladder cancer	0.000139	0.00147	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—HRAS—urinary bladder cancer	0.000139	0.00147	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000138	0.00147	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—NQO1—urinary bladder cancer	0.000131	0.0014	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.00013	0.00138	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—TP53—urinary bladder cancer	0.000129	0.00137	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—HRAS—urinary bladder cancer	0.000128	0.00136	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000124	0.00132	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000124	0.00132	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—HRAS—urinary bladder cancer	0.000124	0.00131	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000121	0.00128	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000121	0.00128	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000115	0.00122	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000112	0.00118	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GSTP1—urinary bladder cancer	0.00011	0.00116	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000108	0.00115	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000108	0.00114	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000106	0.00112	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000106	0.00112	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTZ1—urinary bladder cancer	0.000104	0.00111	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—TYMS—urinary bladder cancer	0.000102	0.00108	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—NCOR1—urinary bladder cancer	0.000101	0.00107	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GSTM1—urinary bladder cancer	0.000101	0.00107	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000101	0.00107	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000101	0.00107	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.0001	0.00106	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	9.98e-05	0.00106	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—NAT1—urinary bladder cancer	9.88e-05	0.00105	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTO2—urinary bladder cancer	9.88e-05	0.00105	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	9.88e-05	0.00105	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GPX1—urinary bladder cancer	9.64e-05	0.00102	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—ERCC2—urinary bladder cancer	9.47e-05	0.00101	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	9.2e-05	0.000978	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.08e-05	0.000964	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	9.03e-05	0.00096	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—MTHFR—urinary bladder cancer	8.9e-05	0.000945	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	8.48e-05	0.000901	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	8.13e-05	0.000864	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	7.73e-05	0.000821	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	7.68e-05	0.000816	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.62e-05	0.00081	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	7.49e-05	0.000795	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PPARG—urinary bladder cancer	7.22e-05	0.000766	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	7.1e-05	0.000755	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.01e-05	0.000744	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CREBBP—urinary bladder cancer	6.93e-05	0.000736	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	6.13e-05	0.000652	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—TYMP—urinary bladder cancer	5.98e-05	0.000636	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	5.82e-05	0.000618	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—NAT1—urinary bladder cancer	5.82e-05	0.000618	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.72e-05	0.000608	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PTGS2—urinary bladder cancer	5.68e-05	0.000603	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—NAT2—urinary bladder cancer	5.41e-05	0.000575	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	5.32e-05	0.000565	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PTEN—urinary bladder cancer	4.95e-05	0.000526	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	4.79e-05	0.000509	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	4.73e-05	0.000503	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—EP300—urinary bladder cancer	4.72e-05	0.000501	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—RRM2—urinary bladder cancer	4.67e-05	0.000496	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	4.52e-05	0.00048	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.49e-05	0.000477	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.49e-05	0.000477	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	4.41e-05	0.000468	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ENO2—urinary bladder cancer	4.33e-05	0.00046	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	4.33e-05	0.00046	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	4.2e-05	0.000446	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	4.11e-05	0.000436	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.7e-05	0.000393	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.53e-05	0.000375	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—TYMP—urinary bladder cancer	3.52e-05	0.000374	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.49e-05	0.000371	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—NQO1—urinary bladder cancer	3.49e-05	0.00037	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.4e-05	0.000361	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.38e-05	0.00036	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—NAT2—urinary bladder cancer	3.19e-05	0.000339	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	2.91e-05	0.000309	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.75e-05	0.000292	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.72e-05	0.000289	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—TYMS—urinary bladder cancer	2.7e-05	0.000287	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	2.67e-05	0.000284	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	2.67e-05	0.000284	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GPX1—urinary bladder cancer	2.56e-05	0.000272	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.55e-05	0.000271	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.55e-05	0.000271	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.53e-05	0.000269	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	2.51e-05	0.000267	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	2.47e-05	0.000262	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.46e-05	0.000261	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.43e-05	0.000258	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	2.36e-05	0.000251	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.12e-05	0.000226	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—NQO1—urinary bladder cancer	2.05e-05	0.000218	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.99e-05	0.000212	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.97e-05	0.000209	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.97e-05	0.000209	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.92e-05	0.000203	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.91e-05	0.000203	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.84e-05	0.000195	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.74e-05	0.000185	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.71e-05	0.000182	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.66e-05	0.000176	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.59e-05	0.000169	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.58e-05	0.000168	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.57e-05	0.000167	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.57e-05	0.000167	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.51e-05	0.00016	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.51e-05	0.00016	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.48e-05	0.000157	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.39e-05	0.000148	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.32e-05	0.00014	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PTEN—urinary bladder cancer	1.31e-05	0.00014	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—EP300—urinary bladder cancer	1.25e-05	0.000133	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.23e-05	0.000131	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.21e-05	0.000129	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.21e-05	0.000129	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.16e-05	0.000124	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.14e-05	0.000121	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.13e-05	0.00012	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.08e-05	0.000115	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.07e-05	0.000114	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	8.87e-06	9.43e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PPARG—urinary bladder cancer	8.7e-06	9.25e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	8.36e-06	8.88e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PTEN—urinary bladder cancer	7.74e-06	8.22e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—EP300—urinary bladder cancer	7.38e-06	7.84e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	6.85e-06	7.27e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PTEN—urinary bladder cancer	5.97e-06	6.34e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—EP300—urinary bladder cancer	5.7e-06	6.05e-05	CbGpPWpGaD
